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Injectable Self-Healing Antibacterial Bioactive Polypeptide-
Based Hybrid Nanosystems for Efficiently Treating 
Multidrug Resistant Infection, Skin-Tumor Therapy,  
and Enhancing Wound Healing
Li Zhou, Yuewei Xi, Yumeng Xue, Min Wang, Yanle Liu, Yi Guo, and Bo Lei*
The surgical procedure in skin-tumor therapy usually results in cutaneous 
defects, and multidrug-resistant bacterial infection could cause chronic 
wounds. Here, for the first time, an injectable self-healing antibacterial bioac-
tive polypeptide-based hybrid nanosystem is developed for treating multidrug 
resistant infection, skin-tumor therapy, and wound healing. The multifunc-
tional hydrogel is successfully prepared through incorporating monodis-
persed polydopamine functionalized bioactive glass nanoparticles (BGN@
PDA) into an antibacterial F127-ε-Poly-L-lysine hydrogel. The nanocomposites 
hydrogel displays excellent self-healing and injectable ability, as well as robust 
antibacterial activity, especially against multidrug-resistant bacteria in vitro 
and in vivo. The nanocomposites hydrogel also demonstrates outstanding 
photothermal performance with (near-infrared laser irradiation) NIR irradia-
tion, which could effectively kill the tumor cell (>90%) and inhibit tumor 
growth (inhibition rate up to 94%) in a subcutaneous skin-tumor model. In 
addition, the nanocomposites hydrogel effectively accelerates wound healing 
in vivo. These results suggest that the BGN-based nanocomposite hydrogel 
is a promising candidate for skin-tumor therapy, wound healing, and anti-
infection. This work may offer a facile strategy to prepare multifunctional 
bioactive hydrogels for simultaneous tumor therapy, tissue regeneration, and 
anti-infection.
DOI: 10.1002/adfm.201806883
1. Introduction
Skin plays an important role in keeping 
body homeostasis and protecting body 
from many noxious substance.[1] Skin 
cancer is diagnosed over a million cases 
every year, which showed high incidence 
in western countries.[2,3] The current 
treatment of skin tumor in clinic mainly 
includes surgical excision, chemo/radio-
therapy and immunotherapy.[3–5] How-
ever, many normal skin tissues around 
the skin-tumor cells must be cleared to 
prevent recurrence, which results in large 
skin defects followed by infection and 
chronic wound healing.[4] Additionally, the 
traditional chemo/radiotherapy has been 
widely used to avoid recurrence, but the 
severe side effect and resistance cause the 
endless pain to patients.[5,6] Until now, it 
is a major challenge to fulfill the cancer 
therapy, wound healing and anti-infection 
after surgical remove of tumor.[7] Specially, 
multidrug resistant bacterial infection was 
one of the key obstacles in chronic wound 
healing.[8] Therefore, it is significant for 
designing novel biomaterials for treating cancer, accelerating 
wound healing, and multidrug resistant bacterial infection. To 
the best of our knowledge, there are very few biomaterials with 
such three functions for efficient skin-tumor therapy.
In recent years, photothermal therapy (PTT) has been 
emerged as a promising strategy to treat various cancers due to 
the high efficiency and low toxicity.[9,10] Various photothermal 
agents have been extensively developed, including many inor-
ganic nanomaterials (gold nanostructures and carbon-based 
nanomaterials) and organic PTT agents such as peptide- and 
protein-based nanomaterials, micelles containing NIR (near-
infrared) dye, organic/inorganic nanocomposites and conju-
gated polymers, and so on.[11–16] Polydopamine (PDA) has been 
employed as important biomaterials based on its excellent bio-
compatibility and lower toxicity in vitro and in vivo. Specially, 
PDA could be used for the tumor therapy owing to its good 
photothermal performance.[17–19] Due to the mussel-inspired 
characteristic, PDA was easily to be deposited on the surface of 
nanoparticles. PDA functionalized nanoparticles are also easily 
to conjugate with other biopolymers through the amidation or 
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Schiff base reaction with PDA. Then, the uniform nanocom-
posites with multifunctional properties could be fabricated via 
the PDA-based chemistry.[18–21] The multifunctional hybrid 
hydrogel based on PDA was also reported for various biomed-
ical applications.[22–24]
Silicon-based bioactive biomaterials such as bioactive 
glass (BG, typical composition: SiO2-CaO-P2O5), have been 
extensively used for bone tissue repair, owing to its good bio-
compatibility, biodegradation, tissue regeneration ability.[25–34] 
Monodispersed BG nanoparticles (BGNs) with enhanced 
biological performance were also developed for bioimaging, 
osteogenic differentiation of stem cells, drugs, and gene 
delivery.[32–38] Recently, it was shown that nanoscale BG could 
enhance chronic wound healing through improving the angi-
ogenesis.[38,39] Thus, various biodegradable nanocomposites 
based on BGNs were fabricated to meet the increased require-
ment of tissue repair and regeneration.[40,41]
Hydrogels based on biodegradable biomaterials have become 
a promising tool for biomedical application owing to their bio-
mimetic mechanical environment and easily preparation to fit 
special needs.[42–47] Some multifunctional hydrogels and novel 
biocompatible polymers have been developed to drug delivery, 
cancer therapy, and bacterial infection and wound healing.[48–53] 
However, multifunctional hydrogel with efficient anti-infection 
ability especially multidrug-resistant antibacterial activity, skin-
tumor therapy, and wound healing are few reported.[44]
Herein, we develop a multifunctional bioactive nanocompos-
ites hydrogel with self-healing and antibacterial capacity against 
multidrug resistant bacteria for PTT of skin tumor and wound 
healing. The multifunctional hydrogel was fabricated through 
the click chemical crosslinking of F127-ε-Poly-L-lysine (FEPL), 
F127-Phe-CHO and BGN@PDA (FCB hydrogel, F: FEPL; C: 
F127-Phe-CHO; B: BGN@PDA). In this strategy, BGN@PDA 
was designed to achieve photothermal effect and stimulate the 
skin repair. FEPL was used to anti-infection, originating from 
EPL which showed high antibacterial activity in our previous 
report,[54] and could form the hydrogel network with F127-Phe-
CHO and BGN@PDA through the Schiff base reaction. The 
synthesis, physicochemical structure and properties, biomed-
ical functions of FCB hydrogel in skin cancer treating, anti-
infection, and skin repair were totally investigated.
2. Results and Discussion
2.1. Fabrication and Characterization of FCB Hydrogel
The synthesis process and application in tumor therapy and 
wound healing of FCB hydrogel are shown in Figure 1. As 
shown in Figure 1A, F127-Phe-CHO and FEPL were synthe-
sized by the reaction of F127-OTs, 4-hydroxybenzaldehyde 
and EPL, respectively. BGN was decorated with PDA by oxida-
tion and polymerization of DA on its surface[55] (Figure 1B). 
FCB hydrogel was performed through a Schiff base process 
between the amino group of FEPL, the aldehyde group of 
F127-Phe-CHO and BGN@PDA, respectively. Additionally, it 
was anticipated that FCB hydrogel has excellent antibacterial 
ability, effective NIR-induced photothermal tumor therapy, and 
enhanced wound healing ability in vivo (Figure 1C).
The chemical structures of the obtained F127-OTs, F127-Phe-
CHO, and FEPL were elucidated by 1H nuclear magnetic reso-
nance (NMR) and Fourier-transform infrared (FTIR) (Figure S1, 
Supporting Information and Figure 2). In 1H NMR spectra, the 
peaks at δ 7.91, 7.29 and 2.48 ppm were belonged to the aromatic 
ring and methyl from TsCl and other strong peak at δ 1.12 ppm 
was attributed to the methyl of F127, indicating the formation of 
F127-OTs (Figure S1A, Supporting Information). The absence of 
methyl peak (2.48 ppm), new resonance signals of the aromatic 
ring at δ 7.81 and 7.01 ppm, aldehyde group at δ 9.87 ppm, 
suggested the formation of F127-Phe-CHO (Figure S1B, Sup-
porting Information). In Figure 2A, the disappearance of proton 
peaks of aromatic ring and five new proton signals at δ 3.79, 
3.15, 1.79, 1.50, and 1.31 ppm assigned as the methine and 
methylene groups of EPL, confirmed the formation of FEPL 
copolymer. The graft ratio of –CHO (≈100%) and EPL (≈100%) 
in F127 were calculated according to the integral values of peaks 
at δ 1.12 ppm (the methyl of F127), δ 9.87 ppm (–CHO), and δ 
3.15 ppm (methylene groups of EPL), respectively.
The chemical structures of F127-OTs, F127-Phe-CHO, 
FEPL, FCE, and FCB hydrogel were further confirmed by FTIR 
(Figure 2B). The skeletal vibration of aromatic ring of F127-OTs 
was at 1600 cm−1. The synthesis of F127-OTs could be con-
firmed thorough the peaks at 2876 and 1099 cm−1 assigned the 
C-H/ether stretch bands from F127. The symmetric vibration 
of carbonyl in aldehyde group of F127-Phe-CHO appeared at 
1687 cm−1. According to the FTIR of the EPL, the absorption 
of ether bands (1099 cm−1) was expected for F127-OTs. The 
disappearance of skeletal vibration of aromatic and presence 
of –NH– stretching band of EPL (3247 cm−1) suggested the 
formation of FEPL. In the FTIR spectrum of the FCE hydro-
gels, the disappearance of bands at 1687 cm−1 (aldehyde) and 
the new peak at 1662 cm−1 (CN), suggesting the Schiff base 
reaction between –CHO groups of F127-Phe-CHO and –NH2 
of FEPL.[62]
However, in FCB hydrogel, due to the probable similar 
crosslinking mechanism between BGN@PDA- F127-Phe-CHO 
and FEPL-F127-Phe-CHO, therefore, no significant change 
was observed in the FTIR spectrum of FCE and FCB hydro-
gels. To demonstrate the interaction between BGN@PDA and 
F127-Phe-CHO, the X-ray photoelectron spectroscopy (XPS) 
analysis was conducted. Additionally, the results of XPS showed 
that the ratio of oxygen to nitrogen in FCB hydrogel (ca. 2.94, 
Figure S2A, Supporting Information) was lower than that of in 
FCE hydrogel (ca. 3.48, Figure S2B, Supporting Information), 
confirming the interaction between F127-EPL and BGN@PDA 
in FCB hydrogel, which leaded to the lower ratio owing to the 
consumption of oxygen in the reaction. There was no signifi-
cant difference in crystalline composition between FCB and 
FCE (Figure S2C, Supporting Information).
The monodispersed PDA-coated BGNs (BGN@PDA) were 
synthesized (shown in SI) and confirmed by UV–vis–NIR and 
transmission electron microscope (TEM) analysis. UV–vis 
spectra displayed an absorption peak at ≈415 nm, belonging 
to PDA (Figure S1C, Supporting Information). The BGN@
PDA showed significant NIR absorption between 800–1000 nm, 
predicted its potential photothermal property (Figure S1C, 
Supporting Information). BGN displayed monodispersed 
mesoporous nanostructure (≈300 nm in diameter) (Figure S1D, 
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Supporting Information). Additionally, BGN@PDA showed 
that a continuous and smooth membrane with a thickness of 
≈20 nm was coated on the surface of the BGN, indicating the 
formation of a layer of PDA film (Figure S1D, Supporting Infor-
mation). After freeze-drying, FCE and FCB hydrogels showed 
representative porous structures. By comparison with the image 
of FCE, some BGN@PDA particles could be found in the image 
of FCB (Figure 2C). Additionally, the characteristic peaks of Si 
in the EDS spectrum of FCB hydrogel further confirmed the 
existence of BGN@PDA in the obtained hydrogels (Figure 2D).
2.2. Rheological, Self-Healing and Injectable Properties
The sol–gel transformation temperatures in hydrogels were 
important for the biomedical applications including tumor 
Adv. Funct. Mater. 2019, 29, 1806883
Figure 1. Scheme showing the preparation and application of FCB hydrogel in tumor therapy and wound healing. A) The synthesis route of F127-OTs 
and FEPL. B) Schematic illustration for the formation of FCB hydrogel and bioapplication.
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therapy and wound healing.[56,57] To evaluate the gelation tempera-
ture of the FCE and FCB hydrogels, dynamic temperature sweep 
rheological experiments were conducted to monitor the gelation 
process. The storage modulus (G′) values in FCB and FCE were 
greater than the loss moduli (G′′) when the temperature was more 
than 30 °C, indicating the formation of hydrogels (Figure S3, Sup-
porting Information). The crossover of modulus (G′ and G″) of 
FCB was about 27.8 °C, which was lower than that of FCE (about 
30.5 °C), suggesting that the BGN@PDA could contribute to the 
formation of hydrogels by the reaction of PDA and –NH2 of FEPL 
as described in Figure 1. At 25 °C, the G′′ of FCB was higher than 
that of G′, indicating its solution state (Figure 3A). When the tem-
perature reached 37 °C, FCB became to gel state (approximately 
55 s) (Figure 3C) owing to the fact of G′ > G′′, suggested the 
temperature-responsive property of FCB hydrogel (Figure 3A,C). 
Moreover, the G′ and G′′ of FCB were higher than that of FCE 
at 37 °C, further confirming the synergies of BGN@PDA in the 
formation of FCB hydrogel networks (Figure S3, Supporting 
Information). The shear-thinning behavior of FCB hydrogel was 
confirmed by the rheological analysis under high and low shear 
strain (Figure 3B). The network of the FCB hydrogels were dis-
rupted by the high shear strain (1000%), resulting in a significant 
decrease in G′ to a level below G″. At the low shear strain (1%), 
the G′ for FCB hydrogels were completely recovered immediately 
(Figure 3B), even after three cycles, demonstrating their rapid 
self-healing and shear-thinning capacity. The self-healing ability 
of FCB hydrogel was also showed through morphological repair 
experiment in which a cavity created in hydrogel. After 6 h, the 
cavity of hydrogel became smaller and disappeared completely 
after 12 h, indicating the good self-healing capability of FCB 
hydrogel (Figure 3D). In addition, the shear-thinning behavior and 
the excellent self-healing of FCB hydrogel enabled the facile injec-
tion capacity without clogging and writing smoothly (Figure 3E).
2.3. Photothermal Properties and Cytotoxicity Evaluation  
of FCB Hydrogel
The temperature changes (Δt) of FCB hydrogel was promoted 
dramatically up to about 40 °C during 9 min (Figure 4A,B). 
Adv. Funct. Mater. 2019, 29, 1806883
Figure 2. Characterization. A) 1H NMR spectra of FEPL in D2O; B) FTIR of precursors and FCB hydrogel; C) Field emission scanning electron micro-
scopy (FESEM) images of FCE and FCB hydrogels; and D) EDS spectrum of FCB hydrogel.
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By contrast, the FCE hydrogel and H2O indicated poor tem-
perature changes at the same conditions. FCB hydrogel 
without NIR irradiation showed no changes in temperature 
and thermal image. These results displayed that the excellent 
photothermal performance of FCB hydrogel was due to the 
incorporation of BGN@PDA. The anticancer efficiency of 
FCB hydrogel in vitro was evaluated in A375 cancer cells. The 
live/dead images of cells showed that a large number of dead 
cells (red fluorescence) were observed in FCB + NIR group 
(Figure 4C). By comparison, the cells in the other five groups 
were almost alive (green fluorescence, Figure 4C). The cell 
viability in FCB + NIR group (10 min) was decreased to 18%, 
significantly lower than that of controls (NC, FCB, and NC+ 
NIR group, Figure 4D). The cell viability of FCB + NIR was 
further decreased with the increasing of irradiation duration 
(9.3% for 20 min). Additionally, the cell viability of hydrogels 
(FCB and FCE) in A375 and C2C12 cells were greater than 
80% even incubation for 24 or 48 h, showing their lower 
cytotoxicity. These results demonstrated the excellent photo-
thermal therapeutic efficiency of FCB hydrogel with better 
biocompatibility in vitro.
2.4. Antibacterial Capacity Evaluation In Vitro/In Vivo
The bacterial infection after surgical tumor therapy has been 
the one of major obstacles in wounding healing,[58,59] there-
fore, the antibacterial efficacy of biomaterials is very important. 
FCB hydrogel exhibited considerable antibacterial-killing ability 
for E. coli and S. aureus, which was equivalent to that of FCE 
(99%), suggesting that BGN@PDA did not affect the antibac-
terial efficacy of FCB (Figure 5A,B). In contrast, BGN@PDA 
and ampicillin showed weak antibacterial activity, in which the 
highest killing efficiencies were 63% and 56% against S. aureus, 
respectively (Figure 5B). In addition, FCB hydrogel also showed 
higher antibacterial activity against MRSA, in which the killing 
efficiency was up to 99%, whereas the corresponding value of 
ampicillin was 24% (Figure 5B).
The anti-infection efficacy of FCB hydrogel in vivo was 
also assessed using MRSA-infected mouse as the model 
(Figure 5C–E). The mice were infected by MRSA through 
subcutaneous injection and were randomly divided into five 
groups (n = 5) after 3 d infection. The antibacterial efficacy was 
evaluated by counting the number of bacteria came from the 
Adv. Funct. Mater. 2019, 29, 1806883
Figure 3. A) Rheological analysis of the FCB hydrogels at 25 °C and 37 °C; B) rheological data of FCB hydrogel under alternating high (1000%) and low 
shear (1%); C) the images of the FCB hydrogel forming; and D,E) images of self-healing and injectability of the FCB hydrogels.
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tissue homogenates plated onto LB-agar plates (Figure 5C, D). 
Mice treated with ampicillin twice displayed a bacterial with 
2.1 × 107 CFU mL−1, similar with control (phosphate buffered 
saline (PBS)-treated group, Figure 5D). By comparison, FCB-
treated group revealed significant less bacteria, in which the 
bacteria burden was 3.75 × 106 CFU mL−1. Additionally, the 
antibacterial efficacy of FCB (≈84%) was significantly higher 
than that of FCE (≈78%) and BGN@PDA (≈51%), suggesting 
that FCB displayed higher antibacterial activity with synergistic 
effect of FCE and BGN@PDA (Figure 5C,D). As depicted in 
Figure 5E, the inflammatory exudates and the macrophages in 
the tissue treated by FCB hydrogel was much less than others, 
demonstrating that the MRSA infection in vivo was signifi-
cantly reduced. The antibacterial performance of FCB hydrogel 
was probably originated from EPL which showed high antimi-
crobial ability against various bacterial.[60,63]
2.5. In Vivo Antitumor Effect of FCB Hydrogel
The antitumor efficacy of FCB hydrogel was further confirmed 
in nude mice with A375 tumor xenografts. After irradiation 
for 10 min on tumor with various groups, the temperature 
change (Δt) was approximately 5 °C for PBS + NIR group and 
FCE + NIR groups, and FCB+NIR group showed the rapid 
improvement for Δt (16 °C) (the temperature of tumor was 
about 51 °C, Figure 6A,B). The tumor volume of FCB + NIR 
group was reduced significantly after PTT for 4 d, while the 
control groups presented a rapid tumor growth (Figure 6C,D). 
The tumor volume in FCB + NIR group was far lower than 
other three controls, which was reduced by 94% compared to 
PBS on day 18 (Figure 6C,D). Additionally, the tumors of FCB + 
NIR group were gradually disappeared without recurrence 
after treatments (day 18, Figure S4, Supporting Information). 
By comparison, FCB without NIR irradiation had no effect on 
tumor inhibition, which showed the comparable tumor volume 
with PBS + NIR and FCE + NIR groups (Figure 6C,D). More-
over, after 18 d treatment, the mean tumor weight in FCB + 
NIR group was the smallest among all groups, indicating that 
FCB hydrogel with NIR efficiently suppressed tumor growth 
(Figure 6E).
H&E and terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) staining were used to evaluate 
the microscopic therapeutic efficacy of FCB hydrogel in vivo. 
A lot of apoptotic tumor cells were seen in FCB + NIR group, 
while cells in controls were well alive (Figure 6F). In addi-
tion, TUNEL+ apoptotic tumor cells of the FCB + NIR group 
was much more than other groups as shown in quantitative 
Adv. Funct. Mater. 2019, 29, 1806883
Figure 4. Photothermal performance and in vitro anticancer efficiency. A,B) The real-time infrared thermal images and photothermal heating curves of 
FCB hydrogel and controls with NIR irradiation (808 nm, 1.41 W·cm−2); C) in vitro anticancer efficiency of FCB hydrogel and controls with or without 
NIR treatment (808 nm, 1.41 W·cm−2, 10 min); D) FCB hydrogel under different irradiation duration (808 nm, 1.41 W·cm−2) (*p < 0.05, **p < 0.01, 
***p < 0.001); and E) the cytotoxicity of FCB hydrogel and each composite in A375 and C2C12 cells.
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analysis (Figure 6G). These results indicated that FCB hydrogel 
could significantly inhibit tumor development by promoting 
apoptosis of cancer cells in vivo owing to its NIR-induced 
hyperthermia.
2.6. In Vivo Wound Healing of FCB Hydrogel
The potential wound healing efficacy of FCB hydrogel was fur-
ther performed in mice with full-thickness skin wound, using 
FCE and commercial dressing (3M) as controls. FCB hydrogels 
presented a higher wound healing rate relative to other groups 
(∗p < 0.05, Figure 7). As compared to FCE and 3M group, on 
day 3 after surgery, the wound area of FCB group was slightly 
reduced and the elevated re-epithelialization was obviously 
detected (Figure 7A,B). The relative wound areas on day 7 for 
the FCB hydrogel, FCE, 3M, and Blank was 33.1%, 53.5%, 
77.6%, and 52.5%, respectively (Figure 7B). The wound defects 
filled with FCB were almost healed on day 10, in which the 
relative wound area was 8.3%, by comparison, 29.2%, 40.7%, 
and 31.8% for FCE, 3M, and Blank groups, respectively. The 
remaining wound area on day 14 for FCB (1.2%) was much 
lower than FCE (4.3%), 3M (24.5%), and Blank groups (13.4%), 
demonstrating that the wound was almost completely healed 
(Figure 7A,B).
Additionally, the H&E images showed that the epidermis 
of FCB group was gradually appeared with the increasing of 
time (Figure S5, Supporting Information). On day 14, relative 
to other groups, abundant granulation tissue (black arrows) 
was observed in FCB group (Figure 7C). Granulation tissue 
included extracellular matrix, fibroblasts, and many growth 
factors, which was beneficial for wound healing process. The 
granulation tissue thickness in FCB hydrogel group displayed 
approximately 240 µm thicker than controls (Figure S5B, 
Supporting Information). Masson’s trichrome staining indi-
cated that more positive staining could be observed in FCB 
Adv. Funct. Mater. 2019, 29, 1806883
Figure 5. Antibacterial activity in vitro and in vivo. A) Pictures of agar plates and B) corresponding statistical data of colonies densities of E. coli, 
S. aureus, and MRSA treated with different samples (*p < 0.05 and **p < 0.01). C) Images of MRSA colonies growing on the agar plates come from 
the homogenized infected tissues after PBS buffer (Control), Ampicillin, BGN@PDA, and FCE and FCB treatments; D) quantitative bacterial colonies 
densities based on C) (*p < 0.05 and **p < 0.01); E) optical images of H&E stained tissue sections after treated with PBS buffer (Control), Ampicillin, 
BGN@PDA, FCE, and FCB, respectively (scale bars: 50 µm).
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group (Figure S6B, Supporting Information), suggesting more 
collagen content in FCB group (Figure 7C and Figure S6, Sup-
porting Information). Additionally, the immunohistochemical 
staining of vascular endothelial growth factor (VEGF) expres-
sion was also performed to analyze the angiogenesis in wound 
healing. There were more VEGF positive vessels (brown, black 
arrows showed) observed in the FCB group than the controls 
(Figure S7A, Supporting Information), and the quantitative 
analysis also confirmed the formation of abundant vessels 
in FCB group (Figure S7B, Supporting Information). These 
results indicated that FCB hydrogel enhanced wound healing 
by promoting the thickness of granulation tissue, collagen 
deposition, and angiogenesis. The antibacterial EPL polypeptide 
and BGN should be responsible for the good performance of 
wound healing. Previous studies showed that antibacterial EPL-
based polypeptide could significantly promote the formation of 
collagen tissue and angiogenesis, and the BGN could enhance 
the formation of blood vessel through activating the hypoxia 
inducible factor.[8,38,39,52] Thus, the FCB hydrogel demonstrated 
the excellent wound healing performance. These results further 
indicated that FCB hydrogel was probably a versatile biomate-
rial for treating infection, cancer, and tissue injury.
As compared to previous multifunctional biomedical 
hydrogel, the as-prepared FCB hydrogel possesses several 
Figure 6. In vivo PTT of FCB hydrogel. A) NIR thermal images of FCB hydrogel and B) photothermal heating curves of A375 tumor-bearing mice treated 
with FCB, FCE, and PBS when treated with or without irradiation (808 nm, 1.41 W·cm−2, 10 min); C) photographs of the tumors after various treat-
ments on day 18; D) tumor volume and E) weight at the end of experiment; F) images of H&E and TUNEL analyses of tumor tissues after treatment 
for 18 d with various formulations. (*p < 0.05 and **p < 0.01, Scale bar: 20 µm); and G) Tunel+ tumor cells in tumor sections quantified by Image-J.
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advantages in wound healing. First, FCB hydrogel demonstrated 
the intrinsical multifunctional capacities including treating 
multidrug-resistant bacterial infection, inhibiting tumor 
growth, and enhancing wound healing. These three biomedical 
functions of FCB hydrogel were few reported for previous bio-
degradable hydrogels, although the wound healing/anti-infec-
tion/antitumor after tumor surgery were rather necessary in 
helping the recovery of patients. Additionally, the components 
in FCB hydrogel including EPL, F127, and BGN have shown 
high biosafety, and the synthesis is facile and suitable for large-
scale production. Compared with other antibacterial agents 
including metal ions and polymer, as a natural polypeptide, 
EPL has the high biocompatibility and excellent broad-spec-
trum activity including multidrug-resistant bacteria.[8,54,59,60] 
EPL-based polymers also demonstrated promising applications 
in tissue regeneration and gene therapy.[8,59] This study pro-
vided a facile strategy to construct a bioactive polypeptide-based 
hydrogel with multifunctional properties for integrated disease 
therapy-tissue regeneration.
3. Conclusions
In summary, a self-healing, injectable, and antibacterial bioac-
tive polypeptide-based nanocomposites hydrogel was developed 
for anti-infection, skin cancer therapy, and skin repair in vitro 
and in vivo. FCB hydrogel showed good self-healing and shear-
thinning behavior with good injectable capacity. FCB hydrogel 
possessed rapid photothermal performance with effectively 
killing cancer cells in vitro with negligible cytotoxicity. Addition-
ally, FCB hydrogel demonstrated high antibacterial capability 
toward E. coli, S. aureus, and MRSA in vitro and in vivo. Impor-
tantly, FCB hydrogel could significantly suppress the tumor 
growth and ablate tumor in vivo through efficient photothermal 
response. FCB hydrogel could also effectively promote the 
wound healing in vivo via stimulating the formation of collagen 
and angiogenesis. This work demonstrates that FCB hydrogel 
is a promising candidate for anti-infection, tumor therapy, and 
wound healing. Additionally, the strategy described in this work 
could be used to prepare other novel hydrogels for multifunc-
tional cancer therapy and tissue regeneration.
4. Experimental Section
Fabrication and Characterizations of FCB Hydrogel: Dibenzaldehy 
determinated F127 (F127-Phe-CHO) and F127-EPL (FEPL) copolymer 
was prepared in a similar method as described previously, as shown in 
Supporting Information.[61,62] The FCB hydrogel was prepared through a 
facile mixing method. Briefly, 20 wt% F127-Phe-CHO aqueous solution, 
40 wt% FEPL aqueous solution and 5 wt% BGN@PDA solution 
aqueous were prepared, respectively. Then, 80 µL BGN@PDA 
solution (0.004 g, 5 wt%) and 70 µL F127-Phe-CHO (0.014 g, 20 wt%) 
solution were added to 250 µL FEPL solution (0.1 g, 40 wt%) at ice. 
After vortexing, the mixture was kept at 37 °C to form hydrogel. The final 
volume percentage of FEPL and BGN@PDA were kept 25 and 1 wt%, 
respectively. Similarly, the hydrogel using 80 µL H2O instead of BGN@
PDA was prepared by the same procedure and used as control, denoted 
Figure 7. In vivo wound healing in mice. A) Representative skin wound photographs on days 0, 3, 7, 10, and 14 and B) wound closure rates of the FCB, 
FCE, and controls (*p < 0.05, **P < 0.01, ***P < 0.001); and C) H&E and Masson’s trichrome staining of wounds after 14 d postsurgery treated with 
FCB hydrogels and controls, fibrin glue. The black arrows show the granulation layers in wound beds. Scale bar is 100 µm.
www.afm-journal.dewww.advancedsciencenews.com
1806883 (10 of 11) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1806883
as FCE (F: FEPL; C: F127-Phe-CHO; E: without BGN@PDA). The 
characterizations procedures of hydrogel were presented in Supporting 
Information.
Rheological Mechanical Properties Evaluations: The rheological property 
(storage G′ and loss modulus G″) of hydrogels were determined by a TA 
rheometer (DHR-2, USA). The hydrogels were placed between the parallel 
plates of 20 nm diameter and with a gap of 1000 µm. The temperature 
effect of various hydrogels in the range of 10–37.5 °C was evaluated by 
keeping the strain and frequency constant at 1% and 1 Hz, respectively. 
The G′ and G″ of hydrogels at 25 °C or 37 °C were also recorded. The 
shear-thinning analysis was carried out through changing the strain 
(from 1% to 1000% with 100 s interval) for three cycles. The time sweeps 
were used to indicate the change of G′ and G″ were recorded by time 
sweeps with fixed temperature (25 °C) and frequency (1 Hz).
Multifunctional Performance Evaluations: The self-healing behavior for 
hydrogels was measured by macroscopic self-healing experiment. Briefly, 
the FCB hydrogel was made into 24-well plates (15 mm diameter, 3 mm 
thickness) with a cavity (4 mm diameter, 3 mm thickness) and placed 
for 6–12 h (25 °C). The self-healing behavior of FCB hydrogel was taken 
by digital photographs. The followed procedure was used to determine 
the injectable ability of FCB hydrogel. 400 µL FCB hydrogel was prepared 
in a 1 mL syringe as described above. The gel was extruded through 
syringe without clogging, once the solution turned into gel state.
The photothermal effects of the FCB hydrogel, FCE, and H2O were 
determined in a 24-well culture plate upon irradiation by a laser (808 nm, 
1.41 W·cm−2, 10 min). FCB without irradiation was used as control. The 
temperature growth curves and thermal imaging was analyzed through a 
machine (Fluke VT04A Visual IR Thermometer) in real time.
In Vitro Photothermal Therapy and Cytotoxicity Assay: A375 cells were 
first cultured under a standard incubation condition (8000 per well, 
DMEM with 10% FBS). After 24 h, the culture solution was changed to 
be 100 µL fresh medium with FCB hydrogel (8 µL, 0.2 µg µL−1 FEPL, 
0.032 µg µL−1 F127-Phe-CHO, 0.08 µg µL−1 BGN@PDA). The cells were 
irradiated by an NIR laser for 10 min (808 nm, 1.41 W·cm−2). As controls, 
cells with FCE and blank were treated with or without laser. The medium 
was removed after 24 h and the cell was washed with PBS for one time. 
Then, the cells activity was measured through a live–dead kit based on 
the manufacture’s protocol and observed by fluorescence microscope 
(IX53, Olympus, Japan). As the cell viability on laser treatment, FCB 
hydrogel treated cells were incubated for 24 h after NIR illumination 
(808 nm, 1.41 W·cm−2 for various times). Cells were grown without FCB 
or with FCB under the same conditions with or without irradiation were 
used as controls. The cell viability was quantified by Alamar Blue kit as 
described previously.[53] To investigate the cytotoxicity of FCB hydrogel 
and each component, A375 and C2C12 cells was employed and the 
experimental procedure was the same as those described above.
Antibacterial Performance Determination: The antibacterial 
performance of various samples was tested through several 
representative bacterials including S. aureus (Gram-positive), methicillin-
resistant Staphylococcus aureus (MRSA), and E. coli (Gram-negative) as 
reported previously.[63] The in vivo antibacterial test was performed on 
a MRSA-infected mouse model. The detailed procedure was shown in 
Supporting Information.
In Vivo Photothermal Tumor Therapy: The subcutaneous melanoma 
tumor model was employed to analyze the in vivo photothermal capacity for 
cancer therapy. The detailed procedure for tumor building and photothermal 
treatment with hydrogels was exhibited in Supporting Information. 
After PTT for 18 d, the mice were sacrificed and the tumor tissues were 
removed. The obtained tumors were captured and weighed. To analyze 
the tissue toxicity, the tumor was fixed by paraformaldehyde in (4% v/v), 
evaluated using hematoxylin-eosin (H&E) and TUNEL analysis. All sections 
were observed using a light microscope (BX53, Olympus, Japan).
In Vivo Wound Healing: The wound healing test of FCB hydrogel 
in vivo was carried out by a full-thickness cutaneous wound model. 
Briefly, the female mice (four-week old, 25–30 g) were anesthetized, 
then a rounded full thickness wound (diameter: 10 mm) was created 
on the back after shaved. The mice were randomized into four groups 
(n = 5) as follows: a control group (Blank), FCB group, FCE group and 
Tegaderm3M group. Then, the wounds were fitted with an FCB or FCE 
hydrogel (50 µL) before coated with hollow Tegaderm.3M The mice did 
not fitted with hydrogel and shielded with or without Tegaderm were 
used as controls. All animal experiments procedures were performed 
according to the protocols approved by the animal care committee of 
Xi’an Jiaotong University.
Digital photographs of wounds were taken on days 0, 3, 7, 10, and 
14, and the wound area was determined by Image-J. The wound size 
was evaluated as follows: relative wound area = St/S0 × 100%, where 
S0 and St were the wound area on day 0 and on day t (t = 3, 7, 10, and 
14), respectively. On 3, 7, 10, and 14 d, specimens of all samples were 
harvested and stained with H&E and Masson’s trichrome based on the 
manufacture’s protocol, respectively. VEGF antibodies were used as the 
markers of angiogenesis in the wound beds in immunohistochemical 
staining. Thereafter, the sections were observed by a light microscope 
(BX53, Olympus, Japan).
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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